These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33986873)

  • 1. Differentiation-related zinc finger protein 750 suppresses cell growth in esophageal squamous cell carcinoma.
    Ana Choi SS; Ko JM; Yu VZ; Ning L; Lung ML
    Oncol Lett; 2021 Jul; 22(1):513. PubMed ID: 33986873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of
    Nambara S; Masuda T; Tobo T; Kidogami S; Komatsu H; Sugimachi K; Saeki H; Oki E; Maehara Y; Mimori K
    Oncol Lett; 2017 Aug; 14(2):1795-1801. PubMed ID: 28789412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
    Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
    Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
    Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.
    Zhang L; Niu X; Bi Y; Cui H; Li H; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820948060. PubMed ID: 32924793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
    Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Iida K; Matsubara H
    Oncology; 2017; 93(3):197-203. PubMed ID: 28558382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
    Yang H; Pan L; Xu C; Zhang Y; Li K; Chen S; Zhang B; Liu Z; Wang LX; Chen H
    Oncol Lett; 2017 Nov; 14(5):5591-5596. PubMed ID: 29113187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
    Hazawa M; Lin DC; Handral H; Xu L; Chen Y; Jiang YY; Mayakonda A; Ding LW; Meng X; Sharma A; Samuel S; Movahednia MM; Wong RW; Yang H; Tong C; Koeffler HP
    Oncogene; 2017 Apr; 36(16):2243-2254. PubMed ID: 27819679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma.
    Bi Y; Guo S; Xu X; Kong P; Cui H; Yan T; Ma Y; Cheng Y; Chen Y; Liu X; Zhang L; Cheng C; Xu E; Qian Y; Yang J; Song B; Li H; Wang F; Hu X; Liu X; Niu X; Zhai Y; Liu J; Li Y; Cheng X; Cui Y
    Cell Death Dis; 2020 Apr; 11(4):296. PubMed ID: 32341351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
    Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
    Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment.
    Pan L; Yang H; Xu C; Chen S; Meng Z; Li K; Chen H
    Biomed Pharmacother; 2018 Sep; 105():566-572. PubMed ID: 29890464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance.
    Wang X; Jia Y; Deng H; Liu Y; Liu Y
    Pathol Res Pract; 2019 Feb; 215(2):308-314. PubMed ID: 30528923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway.
    Xiao Y; Duan Y; Wang Y; Yin X
    Bioengineered; 2021 Dec; 12(1):2863-2873. PubMed ID: 34176441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZNF750 exerted its Antitumor Action in Oral Squamous Cell Carcinoma by regulating E2F2.
    Yang HL; Xu C; Yang YK; Tang WQ; Hong M; Pan L; Chen HY
    J Cancer; 2021; 12(24):7266-7276. PubMed ID: 35003347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.